Gerresheimer
Aktiengesellschaft | |
Traded as | FWB: GXI |
Industry | Manufacturing |
Founded | 1864 |
Founder | Ferdinand Heye |
Headquarters | Düsseldorf, Germany |
Key people | Uwe Roehrhoff (CEO and chairman of the executive board), Dr. Axel Herberg (Chairman of the supervisory board) |
Revenue | €1,377.2 million (2015)[1] |
Number of employees | 10,684 (November 2015)[1] |
Website | www.gerresheimer.com |
Gerresheimer AG (formerly Gerresheimer Glass AG) is a German manufacturer of primary packaging products for medication and drug delivery devices made of special-purpose glass and plastics with headquarters in Düsseldorf.
History
Gerresheimer Glas AG was established in 1864 by Ferdinand Heye, son of the merchant Caspar Hermann Heye (1792–1864). He continued managing the company until 1888, when it was converted into a stock corporation. The company’s name was changed from “Ferd. Heye, Glas-Fabrik, Gerresheim bei Düsseldorf“ into “Actien Gesellschaft der Gerresheimer Glashüttenwerke, vorm. Ferd. Heye, Gerresheim bei Düsseldorf”. When Heye died in 1889, his son Hermann joined the company’s management board aged 23 and was appointed as Board Chairman in 1891. In 1907, Hermann Heye founded “Europäischen Verband der Flaschenfabriken GmbH”. The company purchased the patent rights to the Owens machine, the first fully automated bottling machine, for Europe. It was put into operation at Gerresheimer in 1908. Hermann remained at the helm of the company until his death in 1941. From then on, his son-in-law Niels von Bülow headed the company’s management board as its oldest member.
In 1959 the US company Owens-Illinois of Toledo (Ohio) acquired a 50.1% stake in Gerresheimer, followed by a majority shareholding in 1971. One year later, in 1972, the company name was changed to ”Gerresheimer Glas AG“. From November 1985 onwards, Gerresheimer Glas AG became an independent company again. The new majority shareholder was the Westdeutsche Landesbank (WestLB), which acquired around 58% of the shares in Gerresheimer Glas AG from Owens Illinois. VIAG acquired a majority shareholding in WestLB in 1990. In April 2000, when it merged with VEBA, VIAG sold its majority shareholding in Gerresheimer Glass AG to a consortium led by private equity investor Investcorp in order to fund the foundation of E.ON. This meant Gerresheimer Glas being de-listed from the stock exchange in 2003. The US investment group Blackstone bought the company at the end of 2004.
From the 1990s onwards, Gerresheimer underwent a gradual strategic reorientation. Gerresheimer had been one of the biggest European manufacturers of beer and water bottles. However, this division was spun off and the company shifted its focus to special packaging for the pharmaceutical, life sciences and cosmetics industries.
Gerresheimer Glas AG sold the Gerresheim glassworks and five other production plants to the French company BSN glasspack, a subsidiary of the French Danone Group, in 1999. Owens Illinois acquired BSN glasspack and thereby also the glassworks in Gerresheim in December 2004. In August 2005 the US company Owens Illinois (O-I) closed the Gerresheimer glassworks, formerly the world’s largest bottle manufacturing facility.[2] In the year 2012 Patrizia Immobilien acquired the site of the former glassworks.The Düsseldorf municipal authority and Patrizia Immobilien are implementing housing development projects in Düsseldorf’s former glassmaking district.[3]
The company was taken public (again) in June 2007 after its name had been shortened to Gerresheimer AG. It has been included in the German MDAX stock exchange index since December 2008.[4] The company’s headquarters are still in Düsseldorf.
In 2007 Gerresheimer AG bought the Wilden Group,[5] which today trades under the name of Gerresheimer Regensburg GmbH and is part of the Medical Plastic Systems business unit in the Plastic & Devices division. In 2011 Gerresheimer acquired Brazilian company Tampas Herméticas Védat, which is now known as Gerresheimer Plásticos São Paulo Ltda.[6] In April 2012 Gerresheimer acquired a majority shareholding in the Indian company Neutral Glass & Allied Industries Pvt. Ltd.,[7] followed by Triveni Polymers Ltd. Pvt., a plastic packaging manufacturer for the regulated Indian market, in December of the same year.[7] With five production facilities in South America, five in China and two in India, Gerresheimer is now represented in the fast-growing emerging markets. Uwe Röhrhoff has been CEO of Gerresheimer AG,[8][9] since 2010 and the Supervisory Board Chairman is Gerhard Schulze.[10]
In September 2015 Gerresheimer acquired Centor, the market leader in the US prescription plastic vial retail market for oral drugs.[11]
In November 2015 Gerresheimer sold its tubing operations to the US company Corning Inc. Gerresheimer and Corning have also set up a joint venture to accelerate innovations for the phramaceutical glass packaging market.
Company
Gerresheimer manufactures specialty products made of glass and plastic for the international pharmaceutical and healthcare sector.
The product portfolio includes vials, drug delivery devices, syringe systems, insulin pens and inhalers. The Gerresheimer Group realized revenue of around 1.4 billion euros and had around 11,000 employees at over 40 locations in Europe, North and South America and Asia in 2014.
Gerresheimer’s target group is the pharma and healthcare industry, which it supplies with a comprehensive range of primary packaging products in glass and plastic for drug delivery applications. Gerresheimer also manufactures cosmetic packaging and glass containers for specialty food and beverage industry segments.
In the 2015 financial year (December 1, 2014 to November 30, 2015) revenue increased by 6.8 percent to EUR 1,377,2 million. This was again due in particular to revenue growth in the plastics segment.[12]
Locations
Gerresheimer is a company with international operations at more than 40 locations around the world. It operates production plants in Germany, Poland, Denmark, Belgium, France, Spain, Italy, Switzerland and the Czech Republic. Further production locations are in North and South America (e.g. the USA, Mexico, Brazil and Argentina) as well as China and India.
Key figures
Year | Revenues EUR m | Adjusted EBITDA | Net income EUR m | Employees |
---|---|---|---|---|
2008 | 1.060,1 | 206,4 | 4,5 | 10.177 |
2009 | 1.000,2 | 185,9 | 7,0 | 9.343 |
2010 | 1.024,8 | 204,5 | 46,7 | 9.475 |
2011 | 1.094,7 | 217,3 | 54,4 | 10.212 |
2012 | 1.219,1 | 239,9 | 68,3 | 10.952 |
2013 | 1.265,9 | 249,8 | 68,5 | 11.239 |
2014 | 1.290,0 | 253,4 | 72,9 | 11.096 |
2015 | 1.377,0 | 277,9 | 112,7 | 10.684 |
Divisions
The companies in the Gerresheimer Group are assigned to three divisions.
Plastics & Devices
As a manufacturer of special primary plastic packaging products for the pharmaceuticals industry, the Plastics and Devices Division has a comprehensive portfolio of innovative and excellent quality packaging products for solid, liquid and ophthalmic pharmaceuticals, as well as cosmetics. The Plastics & Devices Division’s product portfolio includes complex, customer-specific products for convenient and safe drug delivery, such as insulin pens, inhalers and pre-fillable syringes. Diagnostics and medical technology products ranging from lancing devices and test systems to plastic packaging for liquid and solid pharmaceuticals with closure and safety systems, are also manufactured by this division.
Primary Packaging Glass
The Primary Packaging Glass Division manufactures glass primary packaging products for pharmaceuticals and cosmetics such as pharmaceutical jars, ampoules, vials, cartridges, perfume flacons and cosmetic cream jars, as well as special glass packaging for the food and beverage industry.
Life Science Research
The Life Science Research Division manufactures a wide range of specialist glass containers and systems made from tubular glass based on paste-mold technology for research, development and analytics applications, as well as general laboratory glassware. Its product portfolio includes beakers, conical flasks and measuring cylinders, plus disposable laboratory glassware articles such as test tubes, pipettes, chromatography vials and other special laboratory glass products.
-
Plastic Packaging
-
Medical Plastic Packaging
-
Syringes
-
Molded glass pharmaceutical containers
-
Pharmaceutical containers made of tubular glass
-
Cosmetic Glass
-
Laboratory Glass
Management Board
Name | Division | Member since |
---|---|---|
Uwe Röhrhoff | Primary Packaging Glass | 2003 |
Rainer Beaujean | Life Science Research | 2012 |
Andreas Schütte | Plastics and Devices | 2009 |
Literature
- Bruno Kammann: Gerresheimer Glas, Geschichte einer Weltfirma (1864–2000), Ein Beitrag zur Wirtschafts-, Sozial- und Stadtgeschichte Düsseldorfs, Klartext Verlag, Essen 2007 ISBN 978-3-89861-782-6.
- Peter Henkel: Industriepfad Düsseldorf. Düsseldorf 2009, ISBN 978-3-7700-1318-0.
- Peter Henkel: 150 Jahre Glashütte Gerresheim. Droste, Düsseldorf 2014, ISBN 978-3-7700-1533-7.
External links
- Carbon Disclosure Project website
References
- 1 2 "Annual Report 2015" (PDF). Gerresheimer. Retrieved 11 february 2016. Check date values in:
|access-date=
(help) - ↑ Glashütte Gerresheim: Totgesagte leben länger auf vdi-nachrichten.com.
- ↑ Ehemalige Glashütte - 1400 Wohnungen on rp-online.de.
- ↑ Gerresheimer AG (4 December 2008). "Gerresheimer steigt in den MDAX auf" (in German). Retrieved 10 April 2010.
- ↑ Gerresheimer kauft Wilden Gruppe on neue-verpackung.de.
- ↑ Gerresheimer acquires Brazilian pharmaceutical plastic packaging company Védat on gerresheimer.com.
- 1 2 Gerresheimer erwirbt den indischen Hersteller von pharmazeutischen Kunststoffverpackungen Triveni on gerresheimer.com.
- ↑ "Uwe Röhrhoff". Bloomberg L.P. Retrieved 2012-03-28.
- ↑ "Gerresheimer: Uwe Röhrhoff ist neuer Vorstandsvorsitzender". New Media Publisher GmbH. 2010-06-23. Retrieved 2012-03-28.
- ↑ Supervisory Board Chairman on gerresheimer.com.
- ↑ Gerresheimer reports good third quarter – Centor acquisition completed on gerresheimer.com.
- ↑ US-Zukauf schiebt Verpackungsspezialisten an on Handelsblatt.com.